2,480 research outputs found
Cephalometric determinants of successful functional appliance therapy
This retrospective study was undertaken to determine the presence of any features on a pretreatment lateral cephalogram that may be used to predict the success of improvement in the sagittal dental base relationship during functional appliance therapy in patients with a Class II skeletal pattern. Seventy-two patients judged to have been successfully treated with a functional appliance were selected for the study. Pre- and posttreatment radiographs were analyzed and the change in the ANB angle was used to determine the skeletal response to treatment. Within the total sample size of 72 patients, two groups were selected. One group of 13 patients who demonstrated a reduction in ANB angle of 3.0° or more were identified as the skeletal group. A second group of 15 patients who demonstrated a change in ANB angle equal to or less than 0.5° were identified as the nonskeletal group. Statistical analysis of these two groups revealed the presence of skeletal and dentoalveolar differences on the pretreatment lateral cephalogram. In the skeletal group, which responded with a favorable skeletal change, the mandible was smaller both in length (P < .01) and ramus height (P < .05) and the anterior and posterior lower face heights were smaller (P < .05). The cranial base was also smaller when compared with the respective lengths in the nonskeletal group
Development and characterization of controlled release mucoadhesive tablets of captopril
El estudio actual trata del desarrollo de los comprimidos mucoadhesivos de captopril, que se diseñaron con el fin de prolongar el tiempo de permanencia gástrica después de la administración oral. Se formularon matrices de comprimidos de captopril mediante diferentes polímeros mucoadhesivos, tales como goma guar, goma xantana, hidroxipropilmetilcelulosa K4M y K15M, a varias concentraciones. Los comprimidos se evaluaron según sus propiedades físicas, uniformidad del contenido, índice de inflamación, fuerza de bioadhesión y liberación farmacológica in vitro. La inflamación se incrementó cuando la concentración y la viscosidad de HPMC aumentaron. Los comprimidos formulados solamente con goma guar y goma xantana se descompusieron con mayor rapidez y se disolvieron completamente en un rango de 5-7 horas, mientras que los comprimidos con HPMC permanecieron intactos y mostraron una liberación lenta de hasta 11-12 horas. Se observó que la formulación F10 con HPMC K15M y goma xantana (1:1) tenía una fuerza bioadhesiva máxima de 31,59±0,05 g y la liberación farmacológica in vitro fue del 91,85%, al final de un periodo de 12 horas con un mecanismo de difusión no de Fick. Los estudios de estabilidad de lotes optimizados mostraron que no hay cambios en la fuerza bioadhesiva y la liberación in vitro cuando se mantiene bajo condiciones de diferentes temperaturas durante 60 días. Se concluyó que la formulación F10 presenta la mejor fuerza bioadhesiva y liberación farmacológica.The present investigation concerns the development of mucoadhesive tablets of Captopril which were designed to prolong the gastric residence time after oral administration. Matrix tablets of Captopril were formulated using different mucoadhesive polymers such as guar gum, xanthan gum, hydroxyl propyl methyl cellulose K4M and K15M in various ratios. The tablets were evaluated for physical properties, content uniformity, swelling index, bioadhesive strength and in-vitro drug release. Swelling was increased as the concentration and viscosity of HPMC increases. Tablets formulated using guar gum and xanthan gum alone were eroded faster and dissolved completely within 5-7 hr, while tablet containing HPMC remain intact and provided slow release up to 11-12 hr. It was evident from the study that the formulation F10 containing HPMC K15M and xanthan gum (1:1) exhibited maximum bioadhesive strength of 31.59±0.05 gm and in vitro drug release was found to be 91.85 % at the end of 12 hr with non-fickian diffusion mechanism. The stability studies of optimized batch showed that there was no change in bioadhesive strength and in-vitro release when stored at different temperature condition for 60 days. It was concluded that formulation F10 shows the better bioadhesive strength and drug release
Mitochondrial respiratory chain deficiency in older men and its relationship with muscle mass and performance
Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats
OBJECTIVE: The aim of this study was to investigate (a) macrophage migration inhibitory factor (MIF) levels in polytrauma patients and rats after haemorrhagic shock (HS), (b) the potential of the MIF inhibitor ISO-1 to reduce multiple organ dysfunction syndrome (MODS) in acute (short-term and long-term follow-up) HS rat models and (c) whether treatment with ISO-1 attenuates NF-κB and NLRP3 activation in HS. BACKGROUND: The MODS caused by an excessive systemic inflammatory response following trauma is associated with a high morbidity and mortality. MIF is a pleiotropic cytokine which can modulate the inflammatory response, however, its role in trauma is unknown. METHODS: The MIF levels in plasma of polytrauma patients and serum of rats with HS were measured by ELISA. Acute HS rat models were performed to determine the influence of ISO-1 on MODS. The activation of NF-κB and NLRP3 pathways were analysed by western blot in the kidney and liver. RESULTS: We demonstrated that (a) MIF levels are increased in polytrauma patients on arrival to the emergency room and in rats after HS, (b) HS caused organ injury and/or dysfunction and hypotension (post-resuscitation) in rats, while (c) treatment of HS-rats with ISO-1 attenuated the organ injury and dysfunction in acute HS models and (d) reduced the activation of NF-κB and NLRP3 pathways in the kidney and liver. CONCLUSION: Our results point to a role of MIF in the pathophysiology of trauma-induced organ injury and dysfunction and indicate that MIF inhibitors may be used as a potential therapeutic approach for MODS after trauma and/or haemorrhage
LEAN MASS, MUSCLE STRENGTH AND GENE EXPRESSION IN COMMUNITY DWELLING OLDER MEN
Sarcopenia is associated with morbidity and mortality. Cellular pathways involved in the regulation of growth and atrophy affect myofibre size and subsequently, muscle strength. The objective of this study was to investigate whether skeletal muscle gene expression was associated with altered lean mass and grip strength in community-dwelling older men
Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case report
A non-smoking 77-year old gentleman of Indian origin was admitted with a 4-month history of intermittent night sweats, haemoptysis and 6 kg of weight loss. CT scan of thorax demonstrated a 2.5 cm mass in the right middle lobe with multiple small nodules within the right lung and confirmed the presence of mediastinal and hilar lymph nodes
Novel role for the innate immune receptor toll-like receptor 4 (TLR4) in the regulation of the wnt signaling pathway and photoreceptor apoptosis
Recent evidence has implicated innate immunity in regulating neuronal survival in the brain during stroke and other neurodegenerations. Photoreceptors are specialized light-detecting neurons in the retina that are essential for vision. In this study, we investigated the role of the innate immunity receptor TLR4 in photoreceptors. TLR4 activation by lipopolysaccharide (LPS) significantly reduced the survival of cultured mouse photoreceptors exposed to oxidative stress. With respect to mechanism, TLR4 suppressed Wnt signaling, decreased phosphorylation and activation of the Wnt receptor LRP6, and blocked the protective effect of the Wnt3a ligand. Paradoxically, TLR4 activation prior to oxidative injury protected photoreceptors, in a phenomenon known as preconditioning. Expression of TNFα and its receptors TNFR1 and TNFR2 decreased during preconditioning, and preconditioning was mimicked by TNFα antagonists, but was independent of Wnt signaling. Therefore, TLR4 is a novel regulator of photoreceptor survival that acts through the Wnt and TNFα pathways. © 2012 Yi et al
Human Skeletal Muscle Possesses an Epigenetic Memory of Hypertrophy
It is unknown if adult human skeletal muscle has an epigenetic memory of earlier encounters with growth. We report, for the first time in humans, genome-wide DNA methylation (850,000 CpGs) and gene expression analysis after muscle hypertrophy (loading), return of muscle mass to baseline (unloading), followed by later hypertrophy (reloading). We discovered increased frequency of hypomethylation across the genome after reloading (18,816 CpGs) versus earlier loading (9,153 CpG sites). We also identified AXIN1, GRIK2, CAMK4, TRAF1 as hypomethylated genes with enhanced expression after loading that maintained their hypomethylated status even during unloading where muscle mass returned to control levels, indicating a memory of these genes methylation signatures following earlier hypertrophy. Further, UBR5, RPL35a, HEG1, PLA2G16, SETD3 displayed hypomethylation and enhanced gene expression following loading, and demonstrated the largest increases in hypomethylation, gene expression and muscle mass after later reloading, indicating an epigenetic memory in these genes. Finally, genes; GRIK2, TRAF1, BICC1, STAG1 were epigenetically sensitive to acute exercise demonstrating hypomethylation after a single bout of resistance exercise that was maintained 22 weeks later with the largest increase in gene expression and muscle mass after reloading. Overall, we identify an important epigenetic role for a number of largely unstudied genes in muscle hypertrophy/memory
Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field.BACKGROUND: Diabetes mellitus, as well as subsequent ocular complications such as cystoid macular edema (CME), are of fundametal socio-economic relevance. Therefore, we evaluated the influence of internal limiting membrane (ILM) removal on longterm morphological and functional outcome in patients with diabetes mellitus (DM) type 2 and chronic CME without evident vitreomacular traction. METHOD: Forty eyes with attached posterior hyaloid were included in this prospective trial and randomized intraoperatively. Prior focal (n = 31) or panretinal (n = 25) laser coagulation was permitted. Group I (n = 19 patients) underwent surgical induction of posterior vitreous detachment (PVD), group II (n = 20 patients) PVD and removal of the ILM. Eleven patients with detached posterior hyaloid (group III) were not randomized, and ILM removal was performed. One eye had to be excluded from further analysis. Examinations included ETDRS best-corrected visual acuity (BCVA), fluorescein angiography (FLA) and OCT at baseline, 3 and 6 months postoperatively. Main outcome measure was BCVA at 6 months, secondary was foveal thickness. RESULTS: Mean BCVA over 6 months remained unchanged in 85% of patients of group II, and decreased in 53% of patients of group I. Results were not statistically significant different [group I: mean decrease log MAR 95% CI (0.06; 0.32), group II: (-0.02; 0.11)]. OCT revealed a significantly greater reduction of foveal thickness following PVD with ILM removal [group I: mean change: 95% CI (-208.95 μm; -78.05 μm), group II: (-80.90 μm: +59.17 μm)]. CONCLUSION: Vitrectomy, PVD with or without ILM removal does not improve vision in patients with DM type 2 and cystoid diabetic macular edema without evident vitreoretinal traction. ILM delamination shows improved morphological results, and appears to be beneficial in eyes with preexisting PVD
- …